Botanix Pharmaceuticals Limited (AU:BOT) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Botanix Pharmaceuticals Limited has issued over 3.4 million new shares, which are now available for immediate trading, following the exercise of equivalent unquoted options. The company, a pioneer in dermatological treatments, recently received FDA approval for Sofdra™, a novel product for primary axillary hyperhidrosis, and is advancing a pipeline of late-stage clinical products for various skin conditions.
For further insights into AU:BOT stock, check out TipRanks’ Stock Analysis page.